Indication

Pyridoxine-dependent seizure

A pyridoxine-dependent seizure is a manifestation of a rare neurometabolic disorder, most commonly pyridoxine-dependent epilepsy, characterized by recurrent, medically intractable seizures that primarily present in neonates and young infants. Read more about Pyridoxine-dependent seizure

35 drugs 32 manufacturers

Advertisement

Drugs that treat it

Common Pyridoxine-dependent seizure therapies.

Showing 19–27 of 35 drugs

Filter & compare in the drug finder →Opens the drug finder with Pyridoxine-dependent seizure preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pyridoxine-dependent seizure.

A pyridoxine-dependent seizure is a manifestation of a rare neurometabolic disorder, most commonly pyridoxine-dependent epilepsy, characterized by recurrent, medically intractable seizures that primarily present in neonates and young infants.

The condition predominantly affects the central nervous system and is most frequently caused by autosomal recessive mutations in the *ALDH7A1* gene encoding antiquitin.

This deficiency leads to the accumulation of lysine degradation intermediates that chemically inactivate pyridoxal 5'-phosphate, an essential cofactor in central neurotransmitter synthesis such as gamma-aminobutyric acid.

Clinically, these seizures—which often present as prolonged convulsions or status epilepticus—are refractory to standard antiseizure medications but rapidly resolve following the administration of pharmacological doses of pyridoxine.

Personalize your experience

Follow Pyridoxine-dependent seizure and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it